UK – mRESVIA RSV vaccine approved to protect patients aged 60 and over

A study found that around 4 months after vaccination, people who received the RSV vaccine had a 79% reduction in their risk of getting lower respiratory tract disease caused by RSV, compared with those who received placebo. The Medicines and Healthcare products Regulatory Agency (MHRA) has approved an mRNA respiratory syncytial virus (RSV) vaccine (brand name mRESVIA) to protect patients aged 60 and over against lower respiratory tract disease caused by RSV. RSV is a common virus that spread...

Publication Details

Journal
Industrias Culturais (Universidade de Coimbra)
Published
2025-05-16
DOI
https://doi.org/10.58079/13xyf
Primary Topic
Respiratory viral infections research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

UK – mRESVIA RSV vaccine approved to protect patients aged 60 and over

Industrias Culturais (Universidade de Coimbra)
Respiratory viral infections research
article

UK – mRESVIA RSV vaccine approved to protect patients aged 60 and over

article en

Abstract

A study found that around 4 months after vaccination, people who received the RSV vaccine had a 79% reduction in their risk of getting lower respiratory tract disease caused by RSV, compared with those who received placebo. The Medicines and Healthcare products Regulatory Agency (MHRA) has approved an mRNA respiratory syncytial virus (RSV) vaccine (brand name mRESVIA) to protect patients aged 60 and over against lower respiratory tract disease caused by RSV. RSV is a common virus that spread...

Industrias Culturais (Universidade de Coimbra)
Good health and well-being
Openalex Percentile: Top 40%
Respiratory viral infections research
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

UK – mRESVIA RSV vaccine approved to protect patients aged 60 and over · Industrias Culturais (Universidade de Coimbra) (2025) | TGRS Research Map | TGRS